ORCA
Online Research @ CardiffÂ
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 3.
Howell, Sacha J., Casbard, Angela  ORCID: https://orcid.org/0000-0001-6241-3052, Carucci, Margherita, Ingarfield, Kate, Butler, Rachel, Morgan, Sian, Meissner, Magdalena, Bale, Catherine, Bezecny, Pavel, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, De Bruin, Elza C., Schiavon, Gaia, Foxley, Andrew and Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496
2022.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial.
The Lancet Oncology
23
(7)
, pp. 851-864.
10.1016/s1470-2045(22)00284-4
|
|
Meissner, Magdalena
2021.
Investigation of biomarker determinants of treatment response of fulvestrant and capivasertib in oestrogen receptor positive breast cancer.
PhD Thesis,
Cardiff University.
Item availability restricted. |
|
|
|
Meissner, Magda and Addeo, Alfredo
2016.
Intrathecal methotrexate and craniospinal radiotherapy can be an effective treatment of carcinomatous meningitis in patients with breast cancer: case reports.
Case Reports in Oncology
9
(3)
, pp. 586-592.
10.1159/000449448
|
|
|
Cardiff University Information Services